ALC logo

Alcon Inc. (ALC)

$68.50

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ALC

Market cap

$34.23B

EPS

1.98

P/E ratio

--

Price to sales

3.85

Dividend yield

0.525%

Beta

0.876302

Price on ALC

Previous close

$66.86

Today's open

$67.28

Day's range

$67.17 - $68.80

52 week range

$61.84 - $92.55

Profile about ALC

CEO

David J. Endicott

Employees

25000

Headquarters

Fribourg,

Exchange

New York Stock Exchange

Shares outstanding

499700000

Issue type

Common Stock

ALC industries and sectors

Healthcare

Medical Equipment & Supplies

News on ALC

Why Alcon (ALC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Jul 14, 2026

news preview

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H

ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.

news source

Zacks Investment Research • Jul 14, 2026

news preview

DELL & 3 More Stocks With Strong Interest Coverage to Buy Now

DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.

news source

Zacks Investment Research • Jul 13, 2026

news preview

Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology

ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.

news source

Zacks Investment Research • Jul 13, 2026

news preview

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook

RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses.

news source

MarketBeat • Jul 11, 2026

news preview

Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know

The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

news source

Zacks Investment Research • Jul 9, 2026

news preview

ALC vs. IDXX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

news source

Zacks Investment Research • Jul 7, 2026

news preview

Here's Why Alcon (ALC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Jul 6, 2026

news preview

Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook.

news source

Zacks Investment Research • Jul 2, 2026

news preview

Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Jun 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Alcon Inc.

Open an M1 investment account to buy and sell Alcon Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ALC on M1